Remove Food Remove Leads Remove Patients Remove Physicians
article thumbnail

Do patients care about accelerated approval drugs?

World of DTC Marketing

Do patients care? The program was codified into law under the Food and Drug Safety and Innovation Act (FDASIA) in 2012. Do patients care? If you’re a cancer patient and your oncologist is prescribing a drug approved via accelerated Approval, are you going to refuse treatment? The answer to that would be “no.”

Patients 200
article thumbnail

Parkinson’s infusion treatment demonstrates advantage over oral delivery

European Pharmaceutical Review

A Phase III trial has shown that compared oral drug delivery, administering levodopa through an infusion pump led to nearly two hours of day (1.72) of additional time in which the medicine reduced symptoms in Parkinson’s patients. There were 381 Parkinson’s patients enrolled in the trial. and Joan A.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Understanding and Adapting to the New Patient Journey

Pharma Marketing Network

But what about patients? And what about the disrupted patient journey? What can our industry do to ensure patients maintain continuity of care at a time when good health is imperative? Reassess the Patient Journey. Enhance Patient Services Programs. Here, we offer four ways pharma marketers can help.

article thumbnail

Leading in Pharma: a woman’s pathway

European Pharmaceutical Review

Now working as a woman in pharma, Dr Ekaterina Malievskaia highlighted her female inspirations in the industry, two of which have held leading roles at Bristol Myers Squibb and the US Food and Drug Administration (FDA). I am a physician by training, and I worked in New York hospital emergency rooms for many years.

Leads 52
article thumbnail

Leading innovators in periodontitis drugs for the pharmaceutical industry

Pharmaceutical Technology

Innovation S-curve for the pharmaceutical industry Periodontitis drugs is a notable innovation area in the pharmaceutical industry Periodontal diseases, which may lead to the damage of teeth or bone, are caused by infections and inflammation of the gums and bone that surround and support the teeth.

Leads 52
article thumbnail

How the US’s pending PIE Act will improve patient access to medication

pharmaphorum

7008), which allows manufacturers to share vital information with healthcare payers and plans while treatments are pending Food and Drug Administration (FDA) approval, was passed by the House of Representatives and is awaiting approval in the Senate. Affecting patient care. The AMCP backed bill (H.R. “Also, the entire bill, H.R.

article thumbnail

UroMems Announces First-Ever Smart Artificial Urinary Sphincter Implant in a Female Patient

Legacy MEDSearch

UroMems , a global company developing innovative, mechatronics technology to treat stress urinary incontinence (SUI), announced today that it has successfully completed the first-ever implant of the UroActive smart, automated artificial urinary sphincter (AUS) in a female patient. Food and Drug Administration).